Pantera

PanTera is a Belgian company specializing in the production of actinium-225 (Ac-225), a promising alpha-emitting radioisotope used in targeted cancer therapies.

Established in 2022 as a joint venture between Ion Beam Applications (IBA) and the Belgian Nuclear Research Centre (SCK CEN), and since 2024 backed by EQT Life Sciences. PanTera aims to enhance the accessibility of innovative cancer treatments by ensuring a reliable supply of Ac-225.To achieve this, PanTera is constructing a state-of-the-art production facility in Mol, Belgium.

Their unique production process involves transforming radium-226 into high-purity Ac-225. This method emphasizes sustainability by recycling and reusing radium, reflecting the company's commitment to environmentally friendly practices.